Literature DB >> 23786645

Effects of exercise on resting blood pressure in obese children: a meta-analysis of randomized controlled trials.

A García-Hermoso1, J M Saavedra, Y Escalante.   

Abstract

The purpose of this meta-analysis was to examine the evidence for the effectiveness of exercise interventions on the resting blood pressure (systolic and diastolic) of obese children. A computerized search was made of seven databases using keywords. Effect sizes (ES) and 95% confidence intervals were calculated, and the heterogeneity of the studies was estimated using Cochran's Q-statistic applied to the effect size means. Nine randomized controlled trial (RCT) studies were selected for review as satisfying the inclusion criteria (n = 205 exercise, 205 control). The main cumulative evidence indicates that the exercise programmes with a frequency of three sessions weekly lasting longer than 60 min had a moderate effect on systolic blood pressure (ES = -0.46, I(2)  = 27%), and programmes of under 12 weeks with more than three sessions weekly were beneficial in terms of reduction of diastolic blood pressure (ES = -0.35, I(2)  = 78%).
© 2013 The Authors. obesity reviews © 2013 International Association for the Study of Obesity.

Entities:  

Keywords:  Children; exercise programme; obesity; physical activity

Mesh:

Year:  2013        PMID: 23786645     DOI: 10.1111/obr.12054

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  16 in total

1.  Exercise for obese youth: refocusing attention from weight loss to health gains.

Authors:  Gabriel Q Shaibi; Justin R Ryder; Joon Young Kim; Estela Barraza
Journal:  Exerc Sport Sci Rev       Date:  2015-01       Impact factor: 6.230

Review 2.  Effects of Exercise Intervention on Health-Related Physical Fitness and Blood Pressure in Preschool Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Antonio García-Hermoso; Alicia M Alonso-Martinez; Robinson Ramírez-Vélez; Mikel Izquierdo
Journal:  Sports Med       Date:  2020-01       Impact factor: 11.136

Review 3.  Exercise-based interventions and C-reactive protein in overweight and obese youths: a meta-analysis of randomized controlled trials.

Authors:  Antonio García-Hermoso; Mairena Sánchez-López; Yolanda Escalante; Jose M Saavedra; Vicente Martínez-Vizcaíno
Journal:  Pediatr Res       Date:  2015-12-21       Impact factor: 3.756

4.  The association between blood pressure and grip strength in adolescents: does body mass index matter?

Authors:  Bin Dong; Zhiqiang Wang; Luke Arnold; Yi Song; Hai-Jun Wang; Jun Ma
Journal:  Hypertens Res       Date:  2016-07-07       Impact factor: 3.872

5.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

6.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 7.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

Review 8.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

9.  2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Authors:  Donald E Casey; Randal J Thomas; Vivek Bhalla; Yvonne Commodore-Mensah; Paul A Heidenreich; Dhaval Kolte; Paul Muntner; Sidney C Smith; John A Spertus; John R Windle; Gregory D Wozniak; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-11-26       Impact factor: 24.094

Review 10.  2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Authors:  Donald E Casey; Randal J Thomas; Vivek Bhalla; Yvonne Commodore-Mensah; Paul A Heidenreich; Dhaval Kolte; Paul Muntner; Sidney C Smith; John A Spertus; John R Windle; Gregory D Wozniak; Boback Ziaeian
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.